APA (7th ed.) Citation

E, T., V, P., A, C., N, M., V, R., N, K., . . . E, K. (2020). Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. Pathology oncology research : POR, 26(4), 2823. https://doi.org/10.1007/s12253-020-00810-6

Chicago Style (17th ed.) Citation

E, Tsiambas, Papanikolaou V, Chrysovergis A, Mastronikolis N, Ragos V, Kavantzas N, Lazaris AC, and Kyrodimos E. "Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19." Pathology Oncology Research : POR 26, no. 4 (2020): 2823. https://doi.org/10.1007/s12253-020-00810-6.

MLA (9th ed.) Citation

E, Tsiambas, et al. "Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19." Pathology Oncology Research : POR, vol. 26, no. 4, 2020, p. 2823, https://doi.org/10.1007/s12253-020-00810-6.